Wealthspire Advisors (New York)’s CONMED CNMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-103
Closed -$4.84K 1390
2025
Q3
$4.84K Buy
+103
New +$5.34K ﹤0.01% 2343

Other funds holding CNMD

Wealthspire Advisors (New York)'s CNMD Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of CONMED (CNMD) in Q4 2025, closing a stake of 103 shares — an estimated $4.84K sold.

Wealthspire Advisors (New York) first reported a position in CNMD in Q3 2025 and held it in 1 quarter. The position peaked at $4.84K in Q3 2025. 265 funds tracked by Wall St. Rank hold CNMD as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining CONMED position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 103 CONMED shares in Q4 2025, an estimated $4.84K.
  • Wealthspire Advisors (New York) first reported a position in CONMED in Q3 2025 and held it in 1 quarter.
  • Wealthspire Advisors (New York)'s CONMED position peaked at $4.84K in Q3 2025.
  • 265 funds tracked by Wall St. Rank held CONMED as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.